Search research articles
Contact Us
Filters
Showing results (21-30 of 127) with videos related to
Page
of 13
Sort By:
British Journal of Haematology
|
October 19, 2021
Population-based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large-cell lymphoma using Public Health England data
Sarah J Halligan, Matthew J Grainge, Nicolas Martinez-Calle, et al.
Seminars in Hematology
|
February 22, 2023
Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management
Eric Tse, Christopher P Fox, Alexander Glover, et al.
American Journal of Hematology
|
May 29, 2021
Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required
Nicolas Martinez-Calle, Matthew R Wilson, Toby A Eyre, et al.
Leukemia & Lymphoma
|
February 6, 2019
Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery
Mark J Bishton, Heather M Long, Alexander C Dowell, et al.
British Journal of Haematology
|
August 11, 2024
Central nervous system prophylaxis in large B-cell lymphoma: A British Society for Haematology Good Practice Paper
Matthew R Wilson, Kate Cwynarski, Toby A Eyre, et al.
Hematological Oncology
|
August 30, 2020
Extended follow-up of CD4<sup>+</sup> T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine
Rafael Gaiolla, Sarah Hartley, Amy Beech, et al.
Haematologica
|
July 2, 2016
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
Jan Styczynski, Walter van der Velden, Christopher P Fox, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 19, 2016
Single-center Series of Bone Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia: High Rates of Sustained Response to Oral Methotrexate
Talha Munir, Mark J Bishton, Ian Carter, et al.
British Journal of Haematology
|
February 23, 2018
Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme
Toby A Eyre, Christopher P Fox, Ali Boden, et al.
Rheumatology (Oxford, England)
|
November 21, 2025
Cost-effectiveness of risk-stratified blood-test monitoring strategies for adults with inflammatory conditions
Matt Stevenson, Georgina Nakafero, Hywel C Williams, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 127) with videos related to
Sort By:
Page
of 13
British Journal of Haematology
|
October 19, 2021
Population-based cohort study of the efficacy of brentuximab vedotin in relapsed systemic anaplastic large-cell lymphoma using Public Health England data
Sarah J Halligan, Matthew J Grainge, Nicolas Martinez-Calle, et al.
Seminars in Hematology
|
February 22, 2023
Extranodal natural killer/T-cell lymphoma: An overview on pathology and clinical management
Eric Tse, Christopher P Fox, Alexander Glover, et al.
American Journal of Hematology
|
May 29, 2021
Interpretation of retrospective data evaluating high-dose methotrexate as central nervous system prophylaxis in diffuse large B-cell lymphoma; caution required
Nicolas Martinez-Calle, Matthew R Wilson, Toby A Eyre, et al.
Leukemia & Lymphoma
|
February 6, 2019
Complete remission of immunochemotherapy-refractory monomorphic post-transplant lymphoproliferative disorder mediated by endogenous T-cell recovery
Mark J Bishton, Heather M Long, Alexander C Dowell, et al.
British Journal of Haematology
|
August 11, 2024
Central nervous system prophylaxis in large B-cell lymphoma: A British Society for Haematology Good Practice Paper
Matthew R Wilson, Kate Cwynarski, Toby A Eyre, et al.
Hematological Oncology
|
August 30, 2020
Extended follow-up of CD4<sup>+</sup> T cell recovery kinetics in a large cohort of patients with B-cell lymphoproliferative disease treated with rituximab-bendamustine
Rafael Gaiolla, Sarah Hartley, Amy Beech, et al.
Haematologica
|
July 2, 2016
Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
Jan Styczynski, Walter van der Velden, Christopher P Fox, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 19, 2016
Single-center Series of Bone Marrow Biopsy-Defined Large Granular Lymphocyte Leukemia: High Rates of Sustained Response to Oral Methotrexate
Talha Munir, Mark J Bishton, Ian Carter, et al.
British Journal of Haematology
|
February 23, 2018
Idelalisib-rituximab induces durable remissions in TP53 disrupted B-PLL but results in significant toxicity: updated results of the UK-wide compassionate use programme
Toby A Eyre, Christopher P Fox, Ali Boden, et al.
Rheumatology (Oxford, England)
|
November 21, 2025
Cost-effectiveness of risk-stratified blood-test monitoring strategies for adults with inflammatory conditions
Matt Stevenson, Georgina Nakafero, Hywel C Williams, et al.
Page
of 13